ARTICLE | Company News
Arrowhead, Merck deal
August 20, 2012 7:00 AM UTC
Arrowhead partnered with Merck to evaluate a mAb from Arrowhead's human-derived peptide targeting and discovery program. Arrowhead gained the program through its acquisition of Alvos Therapeutics Inc...